[Pathogenesis and therapy of pruritus in pregnancy].
Sigl
B
B
Dermatologische und Allergologische Abteilung, Städtisches Krankenhaus, München-Schwabing, Ludwig-Maximilians-Universität.
D000818:Animals; D002780:Cholestasis, Intrahepatic / Q000188:drug therapy / Q000209:etiology*; D002792:Cholestyramine Resin / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006634:Histamine H1 Antagonists / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007231:Infant, Newborn; D010634:Phenobarbital / Q000008:administration & dosage / Q000009:adverse effects; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy / Q000209:etiology*; D011537:Pruritus / Q000188:drug therapy / Q000209:etiology*; D012307:Risk Factors; D014580:Ursodeoxycholic Acid / Q000008:administration & dosage / Q000009:adverse effects
D006634:Histamine H1 Antagonists; D002792:Cholestyramine Resin; D014580:Ursodeoxycholic Acid; D010634:Phenobarbital
Pathogenese und Therapie des Pruritus in graviditate.